ARGX compared with MDGL: revenue, margins and what each company keeps, and the suppliers and customers both name

ARGXArgenx SE

Mkt capRevenueRevenue

MDGLMadrigal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

ARGXArgenx SE

MDGLMadrigal Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ARGX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 22 '26±8.8%▼−1.61%×0.18

MDGL

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±10.5%▼−9.83%×0.93

Q1 FY26±9.2%▲+7.42%×0.80

= impliedARGX realized, solidMDGL realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

Feb 19 '26

±6.2%

▼−11.11%

×1.79

Nov 4 '25±12.9%▲+7.83%×0.60

ARGXArgenx SE

893.85▼−0.45%· post 895.00

Mkt cap$55.3BRevenue—Revenue—

MDGLMadrigal Pharmaceuticals, Inc.

430.17▼−0.35%· post 433.06

ClosedOct 30 '26

Mkt cap$9.9BRevenue$364MQ2 FY26Revenue$958MFY25

Compare

ClosedOct 30 '26

ARGXArgenx SE

MDGLMadrigal Pharmaceuticals, Inc.

893.85▼−0.45%post 895.00

Price

430.17▼−0.35%post 433.06

$55.3B

Mkt cap

$9.9B

—

Revenue

$364MQ2 FY26

—

Revenue

$958MFY25

ARGX893.85▼−0.45%vsMDGL430.17▼−0.35%ClosedOct 30 '26